Close Menu

NEW YORK – Luminex reported on Sunday an 11 percent year-over-year increase in its preliminary fourth quarter revenues.

For Q4 2019, the Austin, Texas-based company recorded $90.4 million in revenues compared to $81.1 million in revenues in the year-ago period. The revenue figure misses the consensus Wall Street estimate of $91.2 million.

Luminex said it anticipates it will be profitable for Q4 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.